Massive study reveals hidden cancer risk in rare gut tumor patients

NCT ID NCT07291752

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study analyzed data from over 93,000 people diagnosed with a gastrointestinal carcinoid tumor between 2000 and 2022. Researchers wanted to find out if these patients are more likely to develop a second, different gastrointestinal cancer. They used a large cancer database to calculate the risk. The study did not involve any new treatments or interventions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARCINOID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

carcinoid tumor neoplasm Neoplasms, Second Primary secondary malignant neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.